Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
September 12, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Medical Components, Inc. is partnering with Truveta to advance the use of real-world data to improve clinical care for patients battling cancer...
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
August 09, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication...
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
May 17, 2023 09:07 ET
|
Truveta
BELLEVUE, Wash., May 17, 2023 (GLOBE NEWSWIRE) -- Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to include new life science...
Truveta collaboration with Harvard University researchers published in JAMA Network Open
May 11, 2023 09:42 ET
|
Truveta
BELLEVUE, Wash., May 11, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced a new research letter published in Jama Network Open using de-identified patient data from Truveta Studio. Published in...
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
April 12, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., April 12, 2023 (GLOBE NEWSWIRE) -- Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for transforming electronic health record (EHR)...
Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials
March 22, 2023 08:45 ET
|
Truveta
BELLEVUE and SEATTLE, Wash., March 22, 2023 (GLOBE NEWSWIRE) -- Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
March 01, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., March 01, 2023 (GLOBE NEWSWIRE) -- Truveta announced the expansion of its de-identified data to include 28 additional social drivers of health (SDOH) attributes – such as education,...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
February 23, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new COVID-19 research published in Vaccine using de-identified patient data from Truveta Studio™. The new research...
New Research: Preeclampsia-related heart failure disproportionately impacts Black mothers
February 08, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new maternal heart health and health equity research from Truveta Studio that explored nearly 500,000 female patient...